| # | Drug | Count |
|---|---|---|
| 0 | PROPYLTHIOURACIL | 2 |
| 1 | VOXELOTOR | 2 |
| 2 | BLEOMYCIN | 1 |
| 3 | BLEOMYCIN SULFATE | 1 |
| 4 | CISPLATIN | 1 |
| 5 | ETOPOSIDE | 1 |
| 6 | FINGOLIMOD HCL | 1 |
| 7 | LABETALOL | 1 |
| 8 | LAMIVUDINE AND ZIDOVUDINE | 1 |
| 9 | NICARDIPINE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PROPYLTHIOURACIL | 2 | 0.0010 |
| 1 | NICARDIPINE HYDROCHLORIDE | 1 | 0.0004 |
| 2 | NICARDIPINE | 1 | 0.0002 |
| 3 | LAMIVUDINE AND ZIDOVUDINE | 1 | 0.0001 |
| 4 | BLEOMYCIN SULFATE | 1 | 0.0001 |
| 5 | VOXELOTOR | 2 | 0.0001 |
| 6 | LABETALOL | 1 | 0.0001 |
| 7 | ETOPOSIDE | 1 | 0.0000 |
| 8 | CISPLATIN | 1 | 0.0000 |
| 9 | FINGOLIMOD HCL | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Hormone Synthesis Inhibitor [EPC] | 2 | 0.0002 |
| 1 | Hemoglobin S Polymerization Inhibitor [EPC] | 2 | 0.0001 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 6 | beta-Adrenergic Blocker [EPC] | 1 | 0.0000 |
| 7 | Dihydropyridine Calcium Channel Blocker [EPC] | 1 | 0.0000 |